MiR-454-3p Promotes Oxaliplatin Resistance by Targeting PTEN in Colorectal Cancer

Colorectal cancer is one of the most common malignancies worldwide. Oxaliplatin is the first-line chemotherapeutic agent for the treatment of advanced colorectal cancer. However, acquired resistance to oxaliplatin limits its therapeutic efficacy, and the underlying mechanism remains largely unclear....

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Xiao-Lan, Zhou, Fang, Xu, Song, Jiang, Jian, Chen, Zhi-Peng, Wang, Shao-Kai, Zuo, Yun, Ni, Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129568/
https://www.ncbi.nlm.nih.gov/pubmed/34017681
http://dx.doi.org/10.3389/fonc.2021.638537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129568/
https://www.ncbi.nlm.nih.gov/pubmed/34017681
http://dx.doi.org/10.3389/fonc.2021.638537

Ejemplares similares